NJ Bio, Inc. is proud to be named Runner-Up in the Best Contract Research Organization (CRO) category at the 2026 World ADC Awards in San Diego, marking seven consecutive years of distinction at this prestigious industry event.
This prestigious award reaffirms NJ Bio’s standing among industry leaders and reflects the scientific excellence of its team, the strength of its collaborations, and the enduring confidence of its clients and partners.
As an integrated CRDMO, NJ Bio continues to advance its capabilities across drug discovery, bioconjugation, analytical development, and GMP manufacturing, supporting the development of next-generation therapeutics.
We extend our heartfelt appreciation to our clients, partners, and the ADC community for being part of this journey. Congratulations to all the winners and nominees of the 2026 World ADC Awards!